Please assess the completion status of the following clinical trial:

Trial Title: Will CPAP Reduce Length Of Respiratory Support In Premature Infants?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Infants born greater than or equal to 28 weeks (28+0) and less than 32 weeks (31+6) gestation admitted to the NICU at a participating center~2. Diagnosis of RDS in the first 24 hours of life requiring intubation for surfactant administration by any combination of the following: Classic clinical signs of RDS include tachypnea, moderate to severe intercostal and subcostal retractions, grunting respirations and oxygen needs of \>0.30 and/or on CPAP of 5 to 6 H2O cm and/or radiographic signs of RDS including low lung volumes, a reticular-granular pattern of lung infiltrates and air bronchograms. A chest radiograph is not a mandatory criterion for the diagnosis of RDS if clinical signs are present~3. Parental consent obtained.~Exclusion Criteria:~1. Infants with a major congenital anomaly~2. Infants with pulmonary hypoplasia; 3. Infants known or suspected to have a neuromuscular disorder;~3. Infants from mothers that had greater than 2 weeks ruptured membranes.~4. Infants that had vigourous resuscitation including chest compressions and cardiac meds.~5. No parental consent obtained.

- Gender: ALL
- Minimum Age: 28 Weeks
- Maximum Age: 32 Weeks
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Mechanical ventilation
- 2 (Type: EXPERIMENTAL): CPAP

Based on this trial design, predict the completion outcome and termination type (if applicable).